These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6030999)

  • 21. A pharmacologic and morphologic study on the nature of the dense-core granules present in the presynaptic endings of sympathetic ganglia.
    Clementi F; Mantegazza P; Botturi M
    Int J Neuropharmacol; 1966 Jul; 5(4):281-5. PubMed ID: 5965640
    [No Abstract]   [Full Text] [Related]  

  • 22. The primate substantia nigra: a Golgi and electron microscopic study.
    Schwyn RC; Fox CA
    J Hirnforsch; 1974; 15(1):95-126. PubMed ID: 4135903
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of drug ,reatment on norepinephrine levels and ultrastructure of the rat hypothalamus and caudate nucleus during a programmed light-dark cycle.
    Walker CA; Speciale SG; Friedman AH
    Neuropharmacology; 1971 May; 10(3):325-34. PubMed ID: 5090141
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoamine effects on neuronal recovery cycles in globus pallidus, caudate nucleus, and substantia nigra.
    Dafny N; Gilman S
    J Neural Transm; 1974; 35(4):275-81. PubMed ID: 4612113
    [No Abstract]   [Full Text] [Related]  

  • 25. The fine structure of cerebellar lesions after L-dopa administration in the dog.
    Reger JF; Holbrook JR; Pozos RS
    Exp Neurol; 1972 Jun; 35(3):480-91. PubMed ID: 5035156
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversal by 3,4-dihydroxyphenylalanine of reserpine-induced regional changes in acetylcholine content in guinea-pig brain.
    Beani L; Ledda F; Bianchi C; Baldi V
    Biochem Pharmacol; 1966 Jul; 15(7):779-84. PubMed ID: 5967896
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of noradrenaline, of dopamine and dihydroxyphenylacetic acid in certain nuclei of rat brain].
    Gérardy J; Quinaux N; Dresse A
    Experientia; 1971 Jan; 27(1):112-3. PubMed ID: 5552690
    [No Abstract]   [Full Text] [Related]  

  • 28. Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment.
    Pericić D; Walters JR
    J Pharm Pharmacol; 1976 Jun; 28(6):527-30. PubMed ID: 7658
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P; Jonsson G; Fuxe K
    Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
    [No Abstract]   [Full Text] [Related]  

  • 31. Do axons of nigro-neostriatal dopamine neurons contain acetylcholinesterase?
    Butcher LL
    Proc West Pharmacol Soc; 1976; 19():102-7. PubMed ID: 995972
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo release of acetylcholinesterase in cat substantia nigra and caudate nucleus.
    Greenfield S; Cheramy A; Leviel V; Glowinski J
    Nature; 1980 Mar; 284(5754):355-7. PubMed ID: 7360271
    [No Abstract]   [Full Text] [Related]  

  • 33. [Correlations between chemical mediators (dopamine, serotonin, acetylcholine and gaba), muscular tone and rapidity of movement].
    Hassler R
    Rev Neurol (Paris); 1972 Jul; 127(1):51-63. PubMed ID: 4358575
    [No Abstract]   [Full Text] [Related]  

  • 34. Electron microscopic investigation of synaptic organization of the trochlear nucleus in cat. I. Normal ultrastructure.
    Bak IJ; Choi WB
    Cell Tissue Res; 1974; 150(3):409-23. PubMed ID: 4367548
    [No Abstract]   [Full Text] [Related]  

  • 35. Rotation produced by administration of dopamine and related substances directly into the supersensitive caudate nucleus.
    Setler PE; Malesky M; McDevitt J; Turner K
    Life Sci; 1978 Sep; 23(12):1277-84. PubMed ID: 713698
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of leponex on the ultrastructure of the brain].
    Uranova NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):1006-11. PubMed ID: 4036421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies.
    Hattori T; McGeer PL; Fibiger HC; McGeer EG
    Brain Res; 1973 May; 54():103-14. PubMed ID: 4350810
    [No Abstract]   [Full Text] [Related]  

  • 38. [Topical organization of the neuronal projections of the substantia nigra and ventral field of the tectum mesencephali onto the head of the caudate nucleus in the cat brain].
    Gorbachevskaia AI
    Arkh Anat Gistol Embriol; 1987 Sep; 93(9):26-34. PubMed ID: 3426407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convergence of excitatory synaptic inputs to caudate spiny neurons.
    Kocsis JD; Sugimori M; Kitai ST
    Brain Res; 1977 Apr; 124(3):403-13. PubMed ID: 851861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
    Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A
    Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.